Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksB.p Marsh Regulatory News (BPM)

Share Price Information for B.p Marsh (BPM)

Share Price is delayed by 15 minutes
Get Live Data
692.00    -3.00 (-0.43%)
Bid:
690.00
Ask:
694.00
Spread: 4.00 (0.58%)
Market Cap: £243.85m
BPM Live PriceLast checked at - London Stock Exchange

Intraday B.p Marsh Share Chart

New Investment

22 Sep 2025 15:23

RNS Number : 3004A
B.P. Marsh & Partners PLC
22 September 2025
 

22 September 2025

 

B.P. Marsh & Partners Plc

("B.P. Marsh", "the Company" or "the Group")

 

New Investment - Salus Capital Partners Limited ("Salus")

 

B.P. Marsh & Partners Plc (AIM: BPM), the specialist private equity investor in early-stage financial services businesses, is pleased to announce that it has acquired a 35% Cumulative Preferred Ordinary shareholding in Salus, a start-up UK-based insurance intermediary group, specialising in Professional Indemnity insurance.

 

B.P. Marsh has agreed to provide funding of up to £2m, via a mixture of equity and a loan facility. The loan facility was partially drawn down upon completion.

 

Salus will operate via two subsidiaries, Forte Professions Limited ("Forte") and Scribe MGA Limited ("Scribe").

Forte is a specialist Professional Indemnity insurance broker, targeting UK-domiciled businesses including Architects, Engineers, Construction, Surveyors, Accountants and Insurance Brokers.

 

Scribe, the underwriting unit of Salus, specialises in Professional Indemnity insurance for small to medium-sized businesses, with an initial focus on Construction, Surveyors and Accountancy. Salus has been founded by four experienced industry practitioners, James Page, Matthew Jones, Dawn Zacharow and Stuart Barker whose collective experience in insurance broking and underwriting within the Professional Indemnity market approaches 100 years.

 

With the backing of B.P. Marsh, the Salus team is committed to establishing a premier, client-focused brokerage and underwriting agency, headquartered in Bristol, providing its clients with access to the speciality Broking and Underwriting services they require.

 

Sophia Gooddy, Associate Director at B.P. Marsh, will be appointed to the Board of Salus alongside Chief Investment Officer, Dan Topping.

 

Dan Topping commented:

 

"We are pleased to be making this investment in Salus, founded by a highly skilled and experienced Management team.

 

"B.P. Marsh looks forward to working with the co-founders to deliver on their business plan of building a successful Professional Indemnity brokerage and underwriting agency.

 

"We believe Salus is an excellent fit for our diversified investment portfolio of insurance intermediaries."

 

James Page, Matthew Jones, Dawn Zacharow and Stuart Barker, the founders of Salus, commented:

 

"We are delighted to partner with B.P. Marsh as we pursue our long-term ambitions, as set out in our business plan.

 

"B.P. Marsh offers Salus more than a financial investment, and the team brings a significant amount of insurance experience, expertise, and relationships. We look forward to working with B.P. Marsh over the years to come to achieve our goals."

 

For further information on B.P. Marsh, its strategy and current portfolio, please visit www.bpmarsh.co.uk or contact: 

 

B.P. Marsh & Partners Plc

Brian Marsh OBE / Alice Foulk

 

+44 (0)20 7233 3112

Nominated Adviser & Joint Corporate Broker:

Panmure Liberum Limited

David Watkins / Atholl Tweedie / Amrit Mahbubani

 

 

+44 (0)20 7886 2500

Joint Corporate Broker:

Singer Capital Markets Advisory LLP

Charles Leigh Pemberton / James Moat / Asha Chotai

 

+44 (0)20 7496 3000

Financial PR & Investor Relations:

Tavistock

Simon Hudson / Katie Hopkins / Kuba Stawiski

 

bpmarsh@tavistock.co.uk

+44 (0)20 7920 3150

 

-Ends-

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCFLFFSALIFFIE
Date   Source Headline
1st Apr 20117:00 amRNSFurther Investment in Insurance Broker
1st Mar 20117:00 amRNSBoard Changes
14th Feb 20117:00 amRNSTrading Update
1st Nov 20101:13 pmRNSChange to Directors' Loan
28th Oct 20107:00 amRNSHalf Yearly Report
24th Sep 20107:00 amRNSNotice of Interim Results
22nd Jul 20102:23 pmRNSCompletion of U.S. Risk (UK) Limited Investment
21st Jul 201012:28 pmRNSResult of AGM
22nd Jun 20109:35 amRNSReplacement - Notice of Annual General Meeting
22nd Jun 20107:00 amRNSNotice of Annual General Meeting
10th Jun 201011:05 amRNSReplacement - Investment in U.S. Risk (UK) Limited
10th Jun 20107:00 amRNSInvestment in U.S. Risk (UK) Limited
9th Jun 20103:22 pmRNSDirectors' Loan
2nd Jun 20107:00 amRNSFinal Results
7th May 20107:00 amRNSNotice of Final Results
21st Jan 20107:00 amRNSDisposal
21st Jan 20107:00 amRNSAcquisition
11th Jan 201012:25 pmRNSDirector's Dealing
14th Dec 200910:16 amRNSDirector's Dealing
27th Oct 20097:00 amRNSInterim Results
26th Oct 20093:26 pmRNSHolding(s) in Company
30th Sep 20097:00 amRNSNotice of Interim Results
23rd Jul 200910:41 amRNSAnnual Report and Accounts
21st Jul 20097:00 amRNSResult of AGM
18th Jun 20094:07 pmRNSNotice of AGM
9th Jun 20099:28 amRNSInvestee Company, Hyperion, Announces Acquisition
3rd Jun 20097:00 amRNSLoans to Investee Company
3rd Jun 20097:00 amRNSFinal Results
18th May 20099:52 amRNSChange of Adviser
6th May 200910:58 amRNSNotice of Results
6th Apr 20093:40 pmRNSHolding(s) in Company
26th Mar 200910:11 amRNSHolding of Shares by a Director
2nd Feb 20097:00 amRNSDirectorate Change
9th Dec 20084:23 pmRNSDirector/PDMR Shareholding
4th Dec 20083:26 pmRNSDirectorate Change
3rd Dec 20084:53 pmRNSDirector/PDMR Shareholding
1st Dec 20083:05 pmRNSChange of Registered Office
18th Nov 20083:06 pmRNSDirector/PDMR Shareholding
12th Nov 200812:42 pmRNSDirector/PDMR Shareholding
28th Oct 20087:00 amRNSInterim Results
6th Oct 20082:16 pmRNSNotice of Interim Results
1st Oct 20087:00 amRNSAppointment of Nominated Adviser
24th Jul 20082:24 pmRNSResult of AGM
25th Jun 20087:00 amRNSNotice of AGM
5th Jun 20087:00 amRNSFinal Results
7th May 20082:33 pmRNSNotice of Results
2nd Apr 20089:05 amRNSHyperion partners with 3i
20th Mar 20087:00 amRNSInvestment in Trillium
11th Mar 20087:01 amRNSInvestment in Business Broker
25th Feb 20084:17 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.